Sarah Vance
Primary Care · Livonia, MINPI 1497000269
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 317 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,134 and has fallen 89.9% since, to $216 in 2025. Among primary care clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 317 payments — averaging $15.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vifor Pharma, Inc.$640
- Fresenius USA Marketing, Inc.$588
- AstraZeneca$465
- Bayer$464
- Merz North America, Inc.$413
- Aurinia Pharma U.S., Inc.$334
- plus $2K from 17 others
What the payments were for
- Food & beverage$4,866100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vifor Pharma, Inc. | 52 | $640 |
| Fresenius USA Marketing, Inc. | 68 | $588 |
| AstraZeneca | 28 | $465 |
| Bayer | 24 | $464 |
| Merz North America, Inc. | 3 | $413 |
| Aurinia Pharma U.S., Inc. | 26 | $334 |
| OPKO Pharmaceuticals, LLC | 19 | $321 |
| Otsuka America Pharmaceutical, Inc. | 16 | $307 |
| Mallinckrodt Hospital Products Inc. | 20 | $300 |
| Travere Therapeutics, Inc. | 16 | $238 |
| Akebia Therapeutics Inc | 13 | $220 |
| Sanofi | 7 | $141 |
| Amgen | 6 | $110 |
| ANI Pharmaceuticals, Inc. | 4 | $79 |
| Calliditas Therapeutics US Inc. | 4 | $75 |
| Novartis | 2 | $42 |
| GSK | 3 | $41 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $20 |
| AbbVie | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Ardelyx, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$235
How this compares
$4,885 in reported general payments places this provider in the 90th percentile of 292 primary care providers in Michigan.
Other primary care in Livonia
- Jessica NarrettLivonia$3K
- Mireille ToumaLivonia$2K
- Donna HamillGrosse Pointe$17K
- Marie Sighe-NzokouLansing$16K
- Alexandria SchwabBay City$10K
- Amy HenryRochester Hills$10K
- Claire GebaraWaterford$9K
- Vanita RobinsonDetroit$9K
- Mary BoudreauMason$9K
- Kimberly FrazierLansing$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.